Expression of CD44 and variant proteins in human colorectal cancer and its relevance for prognosis

Scandinavian Journal of Gastroenterology

Volumn 33, Issue 3, 1998, Pages 301-309

  Ropponen, K M ^b   Eskelinen, M J ^b   Lipponen, P K ^b   Alhava, E ^b   Kosma, V M ^a  

^a UNIVERSITY OF EASTERN FINLAND   (Finland)

^b NONE

Author keywords

Adhesion molecules; CD44; Colorectal cancer; Prognosis

Indexed keywords

CELL ADHESION MOLECULE;

ADULT; AGED; ANTIGEN EXPRESSION; ARTICLE; CANCER GRADING; CANCER RECURRENCE; CANCER SURVIVAL; COLORECTAL CANCER; DISEASE ASSOCIATION; FEMALE; GENE EXPRESSION; HUMAN; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROGNOSIS;

ADULT; AGED; ANTIGENS, CD44; ANTIGENS, NEOPLASM; BIOLOGICAL MARKERS; COLORECTAL NEOPLASMS; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; MIDDLE AGED; NEOPLASM PROTEINS; PROGNOSIS; PROPORTIONAL HAZARDS MODELS; SURVIVAL ANALYSIS;

EID: 0031972103     PISSN: 00365521     EISSN: None     Source Type: Journal    
DOI: 10.1080/00365529850170900     Document Type: Article

References (32)

1. Boring C, Squires T, Tong T. Cancer statistics 1991. CA Cancer J Clin 1991;41:9-36.
2. Hart I, Goode N, Wilson R. Molecular aspects of the metastatic cascade. Biochem Biophys Acta 1989;989:65-84.
3. Picker L, Nakache M, Butcher EC. Monoclonal antibodies to human lymphocyte homing receptors define a novel class of adhesion molecules on diverse cell types. J Cell Biol 1989; 109:927-37.
4. Screaton GR, Bell MV, Jackson DG, Cornelis FB, Gerth W, Bell JI. Genomic structure of DNA encoding the lymphocyte homing receptor CD44 reveals at least 12 alternatively spliced exons. Proc Natl Acad Sci USA 1992;89:12160-4.
5. Rudzki Z, Jothy S. CD44 and the adhesion of neoplastic cells. J Clin Pathol Mol Pathol 1997;50:57-71.
6. Günthert U. Adhesion in leukocyte homing and differentiation. Curr Top Microbiol Immunol 1993;184:45-62.
7. Haynes B, Telen M, Hale L, Denning S. CD44-a molecule involved in leukocyte adherence and T-cell activation. Immunol Today 1989;10:423-8.
8. Günthert U, Hofmann M, Rudy W, Reber S, Zöller M, Haussmann I, et al. A new variant of glycoprotein CD44 confers metastatic potential to rat carcinoma cells. Cell 1991;65: 13-24.
9. Seiter S, Arch R, Reber R, Komitowski D, Hoffmann M, Ponta H, et al. Prevention of tumor metastasis by anti-variant CD44. J Exp Med 1993;177:443-55.
10. Wielenga V, Heider KH, Offerhaus G, Adolf G, van den Berg F, Ponta H, et al. Expression of CD44 variant proteins in human colorectal cancer is related to tumor progression. Cancer Res 1993;53:4754-6.
11. Mulder JW, Kruyt P, Sewnath M, Oosting J, Seldenrijk C, Weidema W, et al. Colorectal cancer prognosis and expression of exon-v6-containing CD44 proteins. Lancet 1994;26:1470-1.
12. Mulder JW, Wielenga V, Polak M, van den Berg F, Adolf G, Herrlich P, et al. Expression of mutant p53 protein and CD44 variant proteins in colorectal tumorigenesis. Gut 1995;36:76-80.
13. Sherman L, Sleeman J, Dall P, Hekele A, Moll J, Ponta H, et al. The CD44 proteins in embryonic development and in cancer. In: Günthert U, Birchmeier W, editors. Attempts to understand metastasis formation. Vol I. Berlin: Springer; 1996. p. 249-67.
14. UICC. In: Hermanek P, Sobin LH, editors. TNM classification of malignant tumours. 4th ed. Springer: Berlin; 1992.
15. Turnbull RB, Kyle K, Watson FB, Spratt J. Cancer of the colon: the influence of the no-touch isolation technique on survival rates. Ann Surg 1967;166:400-27.
16. Goldstein AL, Zhou DFH, Picker LJ, Minty CN, Bargatze RF, Ding JF, et al. A human lymphocyte homing receptor, the Hermes antigen, is related to cartilage proteoglycan core and link proteins. Cell 1989;56:1063-72.
17. Jalkanen S, Bargatze RF, Toyos de los J, Butcher EC. Lymphocyte recognition of high endothelium: antibodies to distinct epitopes of an 85-95-kD glycoprotein antigen differentially inhibit lymphocyte binding to lymph node, mucosal, or synovial endothelial cells. J Cell Biol 1987;105:983-90.
18. Ropponen K, Eskelinen M, Lipponen P, Alhava E, Kosma V-M. Prognostic value of tumour infiltrating lymhocytes (TILs) in colorectal cancer. J Pathol 1997;182:318-24.
19. Cox DR. Regression models and life tables with discussion. J R Stat Soc B 1972;34:187-92.
20. Santra M, Skorski T, Calabretta B, Lattime EC, Iozzo RV. De novo decorin gene expression suppresses the malignant phenotype in human colon cancer cells. Proc Natl Acad Sci 1995;92: 7016-20.
21. Agrez MV, Bates RC. Colorectal cancer and the integrin family of cell adhesion receptors: current status and future directions. Eur J Cancer 1994;30A:2166-70.
22. DeClerck Y, Laug WE. Cooperation between matrixmetallo-proteinases and the plasminogen activator-plasmin system in tumor progression. Enzymes Proteins 1996;49:72-84.
23. Crawford HC, Matrician LM. Tumor and stromal expression of matrix metalloproteinases and their role in tumor progression. Invas Metast 1994-5;14:234-45.
24. Soukka T, Salmi M, Joensuu H, Häkkinen L, Sointu P, Koulu L, et al. Regulation of CD44v6-containing isoforms during proliferation of normal and malignant epithelial cells. Cancer Res 1997;57:2281-9.
25. Zhang L, Underhill C, Chen L. Hyaluronan on the surface of tumor cells is correlated with metastatic behavior. Cancer Res 1995;55:428-33.
26. Thomas L, Byers R, Vink J, Stamenkovic I. CD44H regulates tumor cell migration of hyaluronate-coated substrate. J Cell Biol 1992;18:971-7.
27. Sinn H, Heider K, Scroch P, von Minkwittz G, Kaufman M, Herrlich P, et al. Human mammary carcinomas express homologues of rat metastasis-associated variants of CD44. Breast Cancer Res Treat 1995;36:307-13.
28. Koretz K, Möller P, Lehnert T, Hinz U, Otto HF, Herfart C. Effect of CD44v6 on survival in colorectal carcinoma. Lancet 1995;345:327-8.
29. Finke L, Terpe H-J, Zörb C, Haensch W, Schlag PM. Colorectal cancer prognosis and expression of exon-v6-containing CD44 proteins. Lancet 1995;345:583.
30. Mulder JW, Wielenga WJ, Pals ST, Offerhaus GJ. p53 and CD44 as clinical markers of tumour progression in colorectal carcinogenesis. Histochem J 1997;29:439-52.
31. Bennet K, Jackson DG, Simon JC, Tanczos E, Peach B, Modrell B, et al. CD44 isoforms containing exon v3 are responsible for the presentation of heparin binding growth factors. J Cell Biol 1995;128:687-98.
32. Schlessinger J, Lax I, Lemmon M. Regulation of growth factor activations by proteoglycans: what is the role of the low affinity receptors? Cell 1995;83:357-60.